administration of low-dose aspirin and sulindac , two cyclooxygenase inhibitors selectively sparing renal cyclooxygenase activity , effectively inhibited platelet txa2 production without affecting urinary txb2 excretion , thus ruling out platelets as a possible source of urinary txb2 .
C0221145
platelet
C0005821
platelets